Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,449 | 26,362 | 46,540 | 58,865 | 147,650 |
| Marketable Securities | 64,899 | 86,166 | 54,040 | 118,569 | 136,024 |
| Receivables | 3,406 | 2,746 | 2,822 | 4,557 | 341 |
| Inventories | 11,335 | 10,050 | 9,592 | 15,517 | 6,864 |
| TOTAL | $117,760 | $126,459 | $115,000 | $199,601 | $293,114 |
| Non-Current Assets | |||||
| PPE Net | 6,601 | 9,236 | 14,329 | 18,398 | 12,311 |
| Other Non-Current Assets | 29 | 490 | 354 | 317 | 322 |
| TOTAL | $6,630 | $9,726 | $14,683 | $18,715 | $12,633 |
| Total Assets | $124,390 | $136,185 | $129,683 | $218,316 | $305,747 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,608 | 1,717 | 2,988 | 4,742 | 9,515 |
| Accrued Expenses | 11,441 | 7,905 | 8,204 | 10,258 | 7,994 |
| Other current liabilities | 1,534 | 2,102 | 173 | 140 | 110 |
| TOTAL | $31,489 | $22,555 | $14,743 | $19,376 | $20,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,991 | 13,347 | N/A | 3,075 | 2,114 |
| Deferred Revenues | 12,906 | 10,831 | 3,378 | 4,236 | 3,221 |
| Other Non-Current Liabilities | 3,097 | 4,066 | 4,758 | 2,786 | 2,927 |
| TOTAL | $37,952 | $44,450 | $5,558 | $7,477 | $5,041 |
| Total Liabilities | $69,441 | $67,005 | $20,301 | $26,853 | $25,881 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,516 | 70,459 | 57,497 | 55,064 | 52,896 |
| Common Shares | 74 | 66 | 56 | 632,961 | N/A |
| Retained earnings | -681,473 | -615,313 | -536,020 | -441,555 | -332,167 |
| Other shareholders' equity | 9 | 14 | 30 | 57 | -21 |
| TOTAL | $54,949 | $69,180 | $109,382 | $191,463 | $279,866 |
| Total Liabilities And Equity | $124,390 | $136,185 | $129,683 | $218,316 | $305,747 |